Cargando…
Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
PURPOSE: To evaluate the effect of intravitreal bevacizumab on visual function and retinal thickness in patients with diabetic macular edema (DME). METHODS: Thirty eyes of twenty-eight patients (mean age, 57.9±13.8 years) with DME were included in this study. Complete ophthalmic examination, includi...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Ophthalmological Society
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2655742/ https://www.ncbi.nlm.nih.gov/pubmed/19337474 http://dx.doi.org/10.3341/kjo.2009.23.1.17 |